Zemaira

List of products in the National Drug Code with proprietary name zemaira. This medication is used to treat lung problems (emphysema) caused by a certain inherited disease (alpha-1-proteinase inhibitor deficiency). In people with this condition, lung damage is caused by elastase, a natural substance that the body needs to kill bacteria in the lungs. Normally, a protein (alpha-1-proteinase inhibitor) stops elastase from working when it is no longer needed. However, in people who do not make enough of this protein, elastase does not stop working and damages the lungs. This medication replaces the missing alpha-1-proteinase inhibitor and helps to prevent further lung damage.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0053-7201Zemaira Alpha-1-proteinase Inhibitor HumanKitCsl Behring LlcPlasma Derivative
0053-7202Zemaira .alpha.1-proteinase Inhibitor HumanKitCsl Behring LlcPlasma Derivative
0053-7203Zemaira .alpha.1-proteinase Inhibitor HumanKitCsl Behring LlcPlasma Derivative